RH Tactical Outlook ETF RHTX 深 沪
等待开盘 12-22 09:30:00 美东时间
18.6899
+0.150
+0.81%
华盛通- 最 高18.6899
- 今 开18.61
- 成交量 900股
- 最 低 18.61
- 昨 收 18.5396
- 总市值 885.15万
- 52周最高 18.7918
- 市盈率 静 --
- 换手率 0.19%
- 52周最低 13.87
- 委 比 0.00%
- 总股本 47.36万
- 历史最高 18.7918
- 量 比 0
- 振 幅 0.43%
- 历史最低 10.99
- 每 手 1
- 风险率 1.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan
Radiopharm Theranostics Limited has secured firm commitments for a A$35 million capital raise via a private placement at A$0.03 per share, with Lantheus investing A$7.6 million. A Share Purchase Plan will raise up to A$5 million from eligible shareholders. Participants will receive one free attaching option per share, exercisable at A$0.039 until October 2027. Proceeds will fund drug manufacturing, clinical trials, and working capital, extending ...
10-20 11:30
Resolute Holdings Enhances Board of Directors with the Appointment of Two Additional Independent Directors
Resolute Holdings Management, Inc. announced the appointment of Wayne M. Hewett and Timothy O. Mahoney as independent directors to its Board. Hewett is a seasoned executive leader with experience at Home Depot, Wells Fargo, and General Electric, and currently serves on multiple boards. Mahoney is a veteran aerospace and defense executive, previously leading Honeywell Aerospace and holding roles at Sikorsky Aircraft. David Cote, Executive Chairman...
07-14 12:30
Novo Nordisk, Flagship to develop next-generation obesity drugs
Flagship Pioneering’s Metaphore unit announced a new collaboration with partner Novo Nordisk (NVO) for the research and development of next-generation obesity management treatments. The collaboration ...
2024-05-10 01:22
